Literature DB >> 25971675

Colorectal cancer: A circuitous way to target p53.

Sarah Seton-Rogers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25971675     DOI： 10.1038/nrc3962

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  TP53 loss creates therapeutic vulnerability in colorectal cancer.

Authors:  Yunhua Liu; Xinna Zhang; Cecil Han; Guohui Wan; Xingxu Huang; Cristina Ivan; Dahai Jiang; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Pulivarthi H Rao; Dipen M Maru; Andreas Pahl; Xiaoming He; Anil K Sood; Lee M Ellis; Jan Anderl; Xiongbin Lu
Journal:  Nature       Date:  2015-04-22       Impact factor: 49.962
  1 in total
  3 in total

1.  Long noncoding RNA KCNQ1OT1 promotes colorectal carcinogenesis by enhancing aerobic glycolysis via hexokinase-2.

Authors:  Cheng Chen; Meng Wei; Chao Wang; Danping Sun; Peng Liu; Xin Zhong; Wenbin Yu
Journal:  Aging (Albany NY)       Date:  2020-06-21       Impact factor: 5.682

2.  Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis.

Authors:  Maoyu Li; Fang Peng; Guoqing Li; Yang Fu; Ying Huang; Zhuchu Chen; Yongheng Chen
Journal:  Oncotarget       Date:  2016-06-14

3.  TRIM23 overexpression is a poor prognostic factor and contributes to carcinogenesis in colorectal cancer.

Authors:  Yudong Han; Ye Tan; Yuanyuan Zhao; Yongchun Zhang; Xinjia He; Li Yu; Haiping Jiang; Haijun Lu; Haiying Tian
Journal:  J Cell Mol Med       Date:  2020-03-30       Impact factor: 5.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.